Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain

Completed · Not applicable

Conditions studied: Pneumococcal Pneumonia

In brief

The goals of the study are to determine the pneumococcal polysaccharide vaccination rate in patients with diabetes before and after community pharmacist education and intervention. Assess barriers of receiving the pneumococcal polysaccharide vaccine in patients with diabetes after pharmacist education in a supermarket chain setting

Key facts

Study ID

NCT03851978

Run by

Virginia Commonwealth University

People needed

431

Starts

2018-11-01

Expected to finish

2019-02-28

Last updated by the study team

2019-03-15

Who can join

Age: 19 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with diabetes
• Patients who have filled a prescription for at least one diabetes medication in the past 90 days

You may not qualify if…

• Patients with a known history pneumococcal polysaccharide vaccination
• Patients with an allergy to any component of the pneumococcal polysaccharide vaccine

Where it is running

• Kroger Pharmacy — Midlothian, Virginia, United States
• Kroger Pharmacy — Richmond, Virginia, United States
• Kroger Pharmacy — Richmond, Virginia, United States
• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.